BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
MGLD
The Marygold Companies, Inc.
There isn't enough reported data to score MGLD yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MGLD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| N/A | |
| N/A |
MGLD's revenue is currently healthy, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like MGLD.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
MGLD PE Valuation
MGLD has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MGLD Forward outlook
There aren't enough analyst estimates for MGLD to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MGLD on earnings quality, reporting a profit while its opponent remains loss making.
MGLD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.05 | +$0.06 |
| Q2 2026 | -$0.10 | +$0.04 |
| Q1 2026 | -$0.05 | +$0.10 |
| Q4 2025 | -$0.08 | +$0.06 |
| Q3 2025 | -$0.11 | +$0.02 |
| Q2 2025 | -$0.14 | -$0.04 |
| Q1 2025 | -$0.15 | -$0.12 |
| Q4 2024 | -$0.14 | -$0.12 |
MGLD is still losing money, but far less than before: $0.05 per share over the past year, against $0.15 at its worst in early 2025.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MGLD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MGLD on profitability, with a higher operating margin.
MGLD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.4M | +34% |
| Q2 2026 | $6.9M | -4% |
| Q1 2026 | $7.2M | +2.3% |
| Q4 2025 | $7.6M | -4.5% |
| Q3 2025 | $7M | -12% |
| Q2 2025 | $7.2M | -13% |
| Q1 2025 | $7M | -11% |
| Q4 2024 | $8M | -5.4% |
MGLD's revenue is growing: $9M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +38 points |
| Q2 2026 | -56% | -39 points |
| Q1 2026 | -1.9% | +20 points |
| Q4 2025 | -8.3% | +15 points |
| Q3 2025 | -18% | +9.3 points |
| Q2 2025 | -17% | +17 points |
| Q1 2025 | -21% | -2.7 points |
| Q4 2024 | -23% | -11 points |
MGLD's operating margin was 20% last quarter, up 38 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over MGLD on cash generation, producing positive trailing cash flow while its opponent burns cash.
MGLD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $129K | +$631K |
| Q1 2026 | -$1M | +$148K |
| Q4 2025 | -$908K | -$132K |
| Q3 2025 | -$562K | +$378K |
| Q2 2025 | -$502K | +$217K |
| Q1 2025 | -$1.2M | -$497K |
| Q4 2024 | -$776K | +$79.2K |
| Q3 2024 | -$940K | -452% |
MGLD's free cash flow was −$2M over the past year, against −$3M the year before. Free cash flow isn't a meaningful measure for financial services companies like MGLD.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MGLD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MGLD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +21K shares |
| 1 year | 0% | +18K shares |
| 3 years | +6.4% | +2.6M shares |
| 5 years | +12% | +4.5M shares |
| Available history | +15% | +5.6M shares |
MGLD has 43M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MGLD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2023 | -37.8x | Net Cash |
| Q2 2023 | -3.9x | Net Cash |
| Q1 2023 | -2.9x | Net Cash |
| Q4 2022 | -3.4x | Net Cash |
| Q3 2022 | -2.4x | Net Cash |
| Q2 2022 | -4.2x | Net Cash |
| Q1 2022 | -7.8x | Net Cash |
| Q4 2021 | -4.2x | Net Cash |
MGLD has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MGLD.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MGLD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.2 | Overbought |
| Stochastic | 87.8 | Overbought |
MGLD's weekly RSI is 74 (overbought) and its Stochastic is 88 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
MGLD PE vs Financial Services Sector
| Metric | MGLD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MGLD has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MGLD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.98 | 0% above |
| 20 week MA | $1.44 | 38% above |
| 50 week MA | $1.22 | 62% above |
| 100 week MA | $1.14 | 74% above |
| 200 week MA | $1.22 | 62% above |
MGLD has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MGLD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $2.19 | $1.51 | -31% |
| 2023 | $1.51 | $1.06 | -30% |
| 2024 | $1.06 | $1.81 | +71% |
| 2025 | $1.81 | $0.96 | -47% |
| 2026 YTD | $0.96 | $1.98 | +106% |
MGLD has the edge over BAC on returns for 2026, with the stronger performance.